موافقات الدواء

Linagliptin is indicated in adults with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control as: monotherapy
•when metformin is inappropriate due to intolerance, or contraindicated due to renal impairment.combination therapy
•in combination with other medicinal products for the treatment of diabetes, including insulin,when these do not provide adequate glycaemic control